Diverse biological activities of dandelion

Nutrition Reviews

Volumn 70, Issue 9, 2012, Pages 534-547

  González Castejón, Marta ^a   Visioli, Francesco ^a   Rodriguez Casado, Arantxa ^a  

^a IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Dandelion; Ethnopharmacology; Food; Phytochemicals; Taraxacum officinale

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CALCIUM; CHOLINE; COPPER; DANDELION EXTRACT; INOSITOL; IRON; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; MAGNESIUM; MANGANESE; MINERAL; PHENOL DERIVATIVE; PHOSPHATIDYLCHOLINE; PHOSPHORUS; PLANT EXTRACT; POTASSIUM; REACTIVE OXYGEN METABOLITE; RETINOL; SESQUITERPENE; SILICON; SODIUM; TERPENE; UNCLASSIFIED DRUG; VITAMIN B GROUP; VITAMIN D; ZINC;

ADAPTIVE IMMUNITY; AGING; ANALGESIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BITTER TASTE; CARDIOVASCULAR RISK; CELL VIABILITY; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; DANDELION; DIABETES MELLITUS; FLOWER; FOOD; HISTAMINE RELEASE; HUMAN; HYPERLIPIDEMIA; IMMUNOMODULATION; INFLAMMATION; ISCHEMIA; KIDNEY DISEASE; LIPID PEROXIDATION; LIVER DISEASE; LIVER PROTECTION; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PLANT ROOT; THROMBOSIS; TRADITIONAL MEDICINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; HEALTH FOOD; HUMANS; HYPOGLYCEMIC AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; PLANTS, MEDICINAL; TARAXACUM;

ASTERACEAE; TARAXACUM OFFICINALE;

EID: 84865838096     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00509.x     Document Type: Article

References (134)

1. Fon Quer P. Plantas Medicinales. El Dioscórides Renovado. Barcelona: Editorial Labor SA; 1962.
2. Bisset NG, Phillipson JD, Czygan FC, etal. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. Boca Raton, FL: CRC Press; 1994:486-489.
3. Escudero NL, De Arellano ML, Fernández S, etal. Taraxacum officinale as a food source. Plant Foods Hum Nutr. 2003;58:1-10.
4. Souci SW, Fachmann W, Kraut H. Food Composition and Nutrition Tables. 7th ed. Stuttgart: Med Pharm Scientific; 2008.
5. European Commission Scientific Committee on Food. Opinion of the Scientific Committee on Food on the revision of reference values for nutrition labeling: Brussels: European Commission; 2003
6. Shi S, Zhao Y, Zhou H, etal. Identification of antioxidants from Taraxacum mongolicum by high-performance liquid chromatography-diode array detection-radical-scavenging detection-electrospray ionization mass spectrometry and nuclear magnetic resonance experiments. J Chromatogr. 2008;1209:145-152.
7. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York: John Wiley & Sons, Inc; 1996.
8. Rivera-Núñez D. Taraxacum vulgare (Lam.) Schrank=Taraxacum officinale Weber. In: Aritio LB, ed. La guía de incafo de las plantas útiles y venenosas de la Península Ibérica y Baleares (excluidas medicinales). Madrid: Incafo; 1991:1024-1026.
9. The Lancet Special Analytical Sanitary Commission. The Lancet Special Analytical Sanitary Commission on the composition and value of coffee extracts. Lancet. 1894;144:43-45.
10. Schütz K, Carle R, Schieber A. Taraxacum -a review on its phytochemical and pharmacological profile. J Ethnopharmacol. 2006;107:313-323.
11. Yarnell E, Abascal K. Dandelion Taraxacum officinale and T.mongolicum. Integr Med. 2009;8:35-38.
12. Chevallier A. The Encyclopedia of Medicinal Plants. New York: Dorling Kindersley, Ltd; 1996.
13. Gallaher RN, Gallaher K, Marshall AJ, etal. Mineral analysis of ten types of commercially available tea. J Food Compos Anal. 2006;19:S53-S57.
14. Kalny P, Fijalek Z, Daszczuk A, etal. Determination of selected microelements in Polish herbs and their infusions. Sci Total Environ. 2007;381:99-104.
15. Wichtl M, Bisset NG. Herbal Drugs and Phytopharmaceuticals. Stuttgart: MedPharm Scientific; 1994.
16. Schütz K, Muks E, Carle R, etal. Separation and quantification of inulin in selected artichoke (Cynara scolymus L.) cultivars and dandelion (Taraxacum officinale WEB. ex WIGG.) roots by high-performance anion exchange chromatography with pulsed amperometric detection. Biomed Chromatogr. 2006;20:1295-1303.
17. Kuusi T, Pyysalo H, Autio K. The bitterness properties of dandelion. II. Chemical investigations. Lebensm Wiss Technol. 1985;18:347-349.
18. Westerman L, Roddick JG. Annual variation in sterol levels in leaves of Taraxacum officinale Weber. Plant Physiol. 1981;68:872-875.
19. Hänsel R, Kartarahardja M, Huang J, etal. Sesquiterpenlacton-β-D-glucopyranoside sowie ein neues eudesmanolid aus Taraxacum officinale. Phytochemistry. 1980;19:857-861.
20. Kisiel W, Barszcz B. Further sesquiterpenoids and phenolics from Taraxacum officinale. Fitoterapia. 2000;71:269-273.
21. Schütz K, Kammerer DR, Carle R, etal. Characterization of phenolic acids and flavonoids in dandelion (Taraxacum officinale WEB. ex WIGG.) root and herb by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2005;19:179-186.
22. Williams CA, Goldstone F, Greenham J. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry. 1996;42:121-127.
23. Wolbis M, Krolikowska M, Bednarek P. Polyphenolic compounds in Taraxacum officinale. Acta Pol Pharm. 1993;50:153-159.
24. Akashi T, Furuno T, Takahashi T, etal. Biosynthesis of triterpenoids in cultured cells, and regenerated and wild plant organs of Taraxacum officinale. Phytochemistry. 1994;36:303-308.
25. Burrows S, Simpson J. The triterpene alcohols of Taraxacum root. The triterpene group Part IV. J Chem Soc (Part II).1938:2042-2047.
26. Bradley PR. British Herbal Compendium. Vol 1. Bournemouth, Dorset, UK: British Herbal Medicine Association; 1992:73-75.
27. Budavari S. The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals. 12th ed. Whitehouse Station, NJ: Merck and Co., Inc.; 1996.
28. European Scientific Cooperative on Phytotherapy (ESCOP). Zingiberis rhizoma (ginger). In: Monographs on the Medicinal Uses of Plant Drugs. Exeter, UK.: European Scientific Cooperative on Phytotherapy; 1997.
29. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press; 1996.
30. Hagymási K, Blázovics A, Fehér J, etal. The in vitro effect of dandelion's antioxidants on the microsomal lipid peroxidation. Phytotherapy Res. 2000;14:43-44.
31. Hagymási K, Blázovics A, Lugasi A, etal. In vitro antioxidant evaluation of dandelion (Taraxacum officinale WEB.) water extracts. Acta Aliment. 2000;29:1-7.
32. Budzianowski J. Coumarins, caffeoyltartaric acids and their artifactual methyl esters from Taraxacum officinale leaves. Planta Med. 1997;63:288-289.
33. Wolbis M, Krolikowska M. Polyphenolic compounds of dandelion (Taraxacum officinale). Acta Pol Pharm. 1985;42:215-221.
34. Kristó SZT, Ganzler K, Apati P, etal. Analysis of antioxidant flavonoids from Asteraceae and Moraceae plants by capillary electrophoresis. Chromatographia. 2002;56:121-126.
35. Hu C, Kitts DD. Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro. Phytomedicine. 2005;12:588-597.
36. Booth VH. Taraxien, the carotenoid ester in dandelion flowers. Phytochemistry. 1964;3:229-234.
37. Meléndez-Martínez AJ, Britton G, Vicario IM, etal. HPLC analysis of geometrical isomers of lutein epoxide isolated from dandelion (Taraxacum officinale F.Weber ex Wiggers). Phytochemistry. 2006;67:771-777.
38. Bauer R, Remiger P, Jurcic K, etal. Influence of Echinacea extracts on phagocytotic activity. Z Phytother. 1989;10:43-48.
39. Cheminat A, Zawatzky R, Becker H, etal. Caffeoyl conjugates from Echinacea species: structures and biological activity. Phytochemistry. 1988;27:2787-2794.
40. Facino RM, Carini M, Aldini G, etal. Direct characterization of caffeoyl esters with anti-hyaluronidase activity in crude extracts from Echinacea angustifolia roots by fast atom bombardment tandem mass spectrometry. Farmaco. 1993;48:1447-1461.
41. You Y, Yoo S, Yoon HG, etal. In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress. Food Chem Toxicol. 2010;48:1632-1637.
42. Cho SY, Oh YJ, Park JY, etal. Effect of dandelion (Taraxacum officinale) leaf extracts on hepatic antioxidative system in rats fed high cholesterol diet. J Korean Soc Food Sci Nutr. 2003;32:458-463.
43. Kim J, Noh K, Cho M, etal. Antioxidative, antiinflammatory and antiatherogenic effects of dandelion (Taraxacum officinale) extracts in C57BL/6 mice fed atherogenic diet. FASEB J. 2007;21:862-867.
44. Sumanth M, Rana AC. In vivo antioxidant activity of hydroalcoholic extract of Taraxacum officinale roots in rats. Res Lett. 2006;38:54-55.
45. Choi UK, Lee OH, Yim JH, etal. Hypolipidemic and antioxidant effects of dandelion (Taraxacum officinale) root and leaf on cholesterol-fed rabbits. Int J Mol Sci. 2010;11:67-78.
46. Kim MY, Cheong SH, Kim MH, etal. Leafy vegetable mix supplementation improves lipid profiles and antioxidant status in C57BL/6J mice fed a high fat and high cholesterol diet. J Med Food. 2009;12:877-884.
47. Estabrook RW, Shet MS, Fisher CW, etal. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain. Arch Biochem Biophys. 1996;333:308-315.
48. Hu C, Kitts DD. Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro. J Agric Food Chem. 2003;51:301-310.
49. Kaurinovic B, Popovic M, Cebovic T, etal. Effects of Calendula officinalis L. and Taraxacum officinale WEBER (Asteraceae) extracts on the production of OH• radicals. Fresen Environ Bull. 2003;12:250-253.
50. Popovic M, Kaurinovic B, Mimica-Dukic N, etal. Combined effects of plant extracts and xenobiotics on liposomal lipid peroxidation. Part 3. Dandelion extract - CCl4/fullnerol. Oxid Commun. 2001;24:335-343.
51. Kitts DD, Wijewickreme AN. Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme systems. Plant Foods Hum Nutr. 1994;45:287-294.
52. Pâr A, Jâvor T. Alternatives in hepatoprotection-cytoprotection - influence on monooxygenase system free radical scavengers. Acta Physiol Hung. 1984;64:409-423.
53. Yoo KM, Hwang IK, Moon B. Comparative flavonoids contents of selected herbs and associations of their radical scavenging activity with anti-proliferative actions in V79-4 cells. J Food Sci. 2009;74:419-425.
54. Menghini L, Genovese S, Epifano F, etal. Anti-proliferative, protective and antioxidant effects of artichoke, dandelion, turmeric and rosemary extracts and their formulation. Int J Immunopathol Pharmacol. 2010;23:601-610.
55. Mascolo N, Autore G, Capasso F, etal. Biological screening of Italian medicinal plants for anti-inflammatory activity. Phytotherapy Res. 1987;1:28-31.
56. Tita B, Bello U, Faccendini P, etal. Taraxacum officinale W: pharmacological effect of ethanol extract. Pharmacol Res. 1993;27:23-24.
57. Yasukawa K, Akihisa T, Oinuma H, etal. Inhibitory effect of di- and tri-hydroxy triterpenes from the flowers of compositae on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Biol Pharm Bull. 1996;19:1329-1331.
58. Yasukawa K, Akihisa T, Inoue Y, etal. Inhibitory effect of the methanol extracts from compositae plants on 12-O-tetradecanoyl-phorbol-13-acetate-induced ear oedema in mice. Phytother Res. 1998;12:484-487.
59. Kashiwada Y, Takanaka K, Tsukada H, etal. Sesquiterpene glucosides from anti-leukotriene B4 release fraction of Taraxacum officinale. J Asian Nat Prod Res. 2001;3:191-197.
60. Kim HM, Shin HY, Lim KH, etal. Taraxacum officinale inhibits tumor necrosis factor alpha production from rat astrocytes. Immunopharmacol Immunotoxicol. 2000;22:519-530.
61. Hu C, Kitts DD. Luteolin and luteolin 7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem. 2004;265:107-113.
62. Koh YJ, Cha DS, Ko JS, etal. Anti-inflammatory effect of Taraxacum officinale leaves on lipopolysaccharide-induced inflammatory responses in RAW264.7 Cells. J Med Food. 2010;13:870-878.
63. Park CM, Jin KS, Lee YW, etal. Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-κB translocation in LPS stimulated RAW264.7 cells. Eur J Pharmacol. 2011;660:454-459.
64. Seo SW, Koo HN, An HJ, etal. Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol. 2005;11:597-599.
65. Liu L, Xiong H, Ping J, etal. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice. J Ethnopharmacol. 2010;130:392-397.
66. Lee JP, Li YC, Chen HY, etal. Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involve inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacol Sin. 2010;31:831-838.
67. Jackson LN, Zhou Y, Qiu S, etal. Alternative medicine products as a novel treatment strategy for inflammatory bowel disease. Am J Chin Med. 2008;36:953-965.
68. Swanston-Flatt SK, Day C, Flatt PR, etal. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 1989;10:69-73.
69. Cho SY, Park JY, Oh YJ, etal. Effect of dandelion leaf extracts on lipid metabolism in rats fed high cholesterol diet. J Korean Soc Food Sci Nutr. 2000;29:676-682.
70. Cho SY, Park JY, Park EM, etal. Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin Chim Acta. 2002;317:109-117.
71. Olshansky SJ, Passaro DJ, Hershow RC, etal. A potential decline in life expectancy in the United States in the 21st century. New Engl J Med. 2005;352:1135-1137.
72. Weibel EK, Hadvary P, Hochuli E, etal. Lipstatin: an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J Antibiot. 1987;40:1081-1085.
73. Ballinger A, Peikin SR. Orlistat: its current status as an antiobesity drug. Eur J Pharmacol. 2002;440:109-117.
74. Jandacek RJ, Woods SC. Pharmaceutical approaches to the treatment of obesity. Drug Discov Today. 2004;15:874-880.
75. Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 2007;12:879-889.
76. Weigle DS. Pharmacological therapy of obesity: past, present, and future. J Clin Endocrinol Metab. 2003;88:2462-2469.
77. Zhang J, Kang MJ, Kim MJ, etal. Pancreatic lipase inhibitory activity of Taraxacum officinale in vitro and in vivo. Nutr Res Pract. 2008;2:200-203.
78. Moreno DA, Ripoll C, Ilic N, etal. Inhibition of lipid metabolic enzymes using Mangifera indica extracts. J Food Agric Environ. 2006;4:21-26.
79. Shin JE, Han MJ, Kim DH. 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase. Biol Pharm Bull. 2003;26:854-857.
80. Yamamoto M, Shimura S, Itoh Y, etal. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int J Obes. 2000;24:758-764.
81. Petlevski R, Hadzija M, Slijepcevic M, etal. Glutathione S-transferase and malondialdehyde in the liver of NOD mice on short-term treatment with plant mixture extract P-980191. Phytother Res. 2003;17:311-314.
82. Hussain Z, Waheed A, Qureshi RA, etal. The effect of medicinal plants of Islamabad and Murree region of Pakistan on insulin secretion from INS-1 cells. Phytother Res. 2004;18:73-77.
83. Petlevski R, Hadzija M, Slijepcevic M, etal. Effect of "anti-diabetis" herbal preparation on serum glucose and fructosamine in NOD mice. J Ethnopharmacol. 2001;75:181-184.
84. Önal S, Timur S, Okutucu B, etal. Inhibition of α-glucosidase by aqueous extract of some potent anti-diabetic medicinal herbs. Prep Biochem Biotechnol. 2005;35:29-36.
85. Neef H, Cilli F, Declerck PJ, etal. Platelet anti-aggregating activity of Taraxacum officinale Weber. Phytother Res. 1996;10:138-140.
86. Koo HN, Hong SH, Song BK, etal. Taraxacum officinale induces cytotoxicity through TNF-α and IL-1a secretion in HepG2 cells. Life Sci. 2004;74:1149-1157.
87. Baba K, Abe S, Mizuno D. Antitumor activity of hot water extract of dandelion, Taraxacum officinale - correlation between antitumor activity and timing of administration [author's transl]. J Pharm Soc J. 1981;101:538-543.
88. Sigstedt SC, Hooten CJ, Callewaert MC, etal. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol. 2008;32:1085-1090.
89. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291-3310.
90. Takasaki M, Konoshima T, Tokuda H, etal. Anticarcinogenic activity of Taraxacum plant. I. Biol Pharm Bull. 1999;22:602-605.
91. Takasaki M, Konoshima T, Tokuda H, etal. Anti-carcinogenic activity of Taraxacum plant. II. Biol Pharm Bull. 1999;22:606-610.
92. Ovesna Z, Vachalkova A, Horvathova K. Taraxasterol and β-sitosterol: new naturally compounds with chemoprotective/chemopreventive effects. Neoplasma. 2004;51:407-414.
93. Hata K, Ishikawa K, Hori K, etal. Differentiation inducing activity of lupeol, a lupane triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biol Pharm Bull. 2000;23:962-967.
94. Hata K, Mukaiyama T, Tsujimura N, etal. Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell line. Cytotechnology. 2006;52:151-158.
95. Kekre N, Griffin C, McNulty J, etal. Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidylserine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol. 2005;56:29-38.
96. Ma P, Dong X, Swadley CL, etal. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol. 2009;5:151-161.
97. Ovadje P, Chatterjee S, Griffin C, etal. Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol. 2010;133:86-91.
98. Chatterjee SJ, Ovadje P, Mousa M, etal. The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells. Evid Based Complement Alternat Med. 2011;2011:129045.
99. Hueber A, Zornig M, Bernard A, etal. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. J Biol Chem. 2000;275:10453-10462.
100. Risau W. Differentiation of endothelium. FASEB J. 1995;9:926-933.
101. Tong Y, Zhang X, Zhao W, etal. Antiangiogenic effects of shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. Eur J Pharmacol. 2004;494:101-109.
102. Jeon HJ, Kang HJ, Jung HJ, etal. Anti-inflammatory activity of Taraxacum officinale. J Ethnopharmacol. 2008;115:82-88.
103. Singh A, Malhotra S, Subban R. Dandelion (Taraxacum officinale) - hepatoprotective herb with therapeutic potential. Pharmacog Rev. 2008;2:163-167.
104. Maliakal PP, Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol. 2001;53:1323-1329.
105. Mahesh A, Jeyachandran R, Cindrella L, etal. Hepatocurative potential of sesquiterpene lactones of Taraxacum officinale on carbon tetrachloride induced liver toxicity in mice. Acta Biol Hung. 2010;61:111-121.
106. Park CM, Youn HJ, Chang HK, etal. TOP1 and 2, polysaccharides from Taraxacum officinale, attenuate CCl(4)-induced hepatic damage through the modulation of NF-kappaB and its regulatory mediators. Food Chem Toxicol. 2010;48:1255-1261.
107. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524-529.
108. Domitrovi R, Jakovac H, Romi Z, etal. Anti-fibrotic activity of Taraxacum officinale root in carbon tetrachloride-induced liver damage in mice. J Ethnopharmacol. 2010;130:569-577.
109. Chabrol E, Charonnat R, Maximin M, etal. L'action choleretique des Composes. CR Soc Biol. 1931;108:1100-1102.
110. Böhm K. Choleretic action of various plant drugs [in German]. Arzneimittelforschung. 1959;9:376-378.
111. Blumenthal M, Busse WR, Goldberg A, etal. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston: Integrative Medicine Communications; 1998:155-156.
112. Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integrative Medicine Communications; 2002:78-83.
113. Faber K. The dandelion Taraxacum officinale Weber [in German]. Pharmazie. 1958;13:423-436.
114. Chakurski I, Matev M, Koichev A, etal. Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinalis, Calendula officinalis and Foeniculum vulgare [in Bulgarian]. Vutr Boles. 1981;20:51-54.
115. Tyler VE. Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 2nd ed. Philadelphia: GF Stickley Co.; 1987.
116. Liu XR, Han WQ, Sun DR. Treatment of intestinal metaplasia and atypical hyperplasia of gastric mucosa with xiao wei yan powder [in Chinese]. Chin J Integr Trad West Med. 1992;12:602-603.
117. Shi H, Dong L, Bai Y, etal. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol. 2009;623:119-124.
118. Trojanová I, Rada V, Kokoska V, etal. The bifidogenic effect of Taraxacum officinale root. Fitoterapia. 2004;75:760-763.
119. Rácz-Kotilla E, Rácz G, Solomon A. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med. 1974;26:212-217.
120. Grases F, Melero G, Costa-Bauzá A, etal. Urolithiasis and phytotherapy. Int Urol Nephrol. 1994;26:507-511.
121. Clare BA, Conroy RS, Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern Complem Med. 2009;15:929-934.
122. Zheng M. Experimental study of 472 herbs with antiviral action against herpes simplex virus [in Chinese]. J Tradit Chin Med. 1990;10:39-41.
123. Sengul M, Yildiz H, Gungor N, etal. Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak J Pharm Sci. 2009;22:102-106.
124. Luo ZH. The use of Chinese traditional medicines to improve impaired immune functions in scald mice. Chin J Plast Surg Burn. 1993;9:56-58.
125. Yoon TJ. Effect of water extracts from root of Taraxacum officinale on innate and adaptive immune responses in mice. Korean J Food Nutr. 2008;21:275-282.
126. Woolfe G, Macdonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 1944;80:300-307.
127. Hendershot LC, Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J Pharmacol Exp Ther. 1959;125:237-240.
128. Zhi X, Honda K, Ozaki K, etal. Dandelion T-1 extract up-regulates reproductive hormone receptor expression in mice. Int J Mol Med. 2007;20:287-292.
129. Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester, VT: Healing Arts Press; 2003.
130. Blumenthal M, Goldberg A, Brinkmann J. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integrative Medicine Communications; 2000.
131. Heinrich M, Barnes J, Gibbons S, etal. Fundamentals of Pharmacognosy and Phytotherapy. Edinburgh: Churchill Livingstone; 2004.
132. Yao LH, Jiang YM, Shi J, etal. Flavonoids in food and their health benefits. Plant Foods Hum Nutr. 2004;59:113-122.
133. Visioli F, Borsani L, Galli C. Review - Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res. 2000;47:419-425.
134. Visioli F, Bogani P, Grande S, etal. Review - local food and cardioprotection: the role of phytochemicals. Forum Nutr. 2006;59:116-129.